Industrial supplies distributor Turner Supply has acquired Progressive Supply — a Woodstock, GA-based provider of MRO solutions. Representing Turner Supply’s entry into the Atlanta and North Georgia ...

Abstract: In the domain of infrared small target detection (IRSTD), the challenges revolve around detecting small and faint targets from infrared images. These targets lack distinct textures and ...

New Jersey progressive candidate Analilia Mejia is the projected winner of the Democratic nomination in the race for Gov. Mikie Sherrill’s (D) former House seat, Decision Desk HQ (DDHQ) announced ...

The Progressive Corporation (NYSE:PGR) is one of the best long-term retirement stocks. On February 2, UBS cut its price target on Progressive Corporation (NYSE:PGR) to $226 from $234 but kept a Buy ...

Progressive Insurance is quietly testing the market for another big slice of real estate next to its Mayfield Village headquarters, putting a roughly 56-acre, heavily wooded tract at 520 Som Center ...

Progressive activist Analilia Mejia has defeated former Rep. Tom Malinowski and a crowded field of Democratic contenders in the special primary for New Jersey Gov. Mikie Sherrill’s old district in ...

Progressive activist Analilia Mejia won the Democratic primary in a special election to represent the New Jersey suburbs in Congress, a significant win for the left in the ongoing battles over the ...

In a massive turn of events with national implications, progressive advocate Analilia Mejia declared victory Tuesday in the special Democratic primary election for Gov. Mikie Sherrill’s old U.S. House ...

Roche announced new late-breaking data from the phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib met its primary endpoint of non-inferiority ...

In a recent column I urged readers to wrench part of their mind away from the rush of Trump-era controversies and pay more attention to artificial intelligence. No sooner had I made this case then the ...

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...